SAB Biotherapeutics Inc. Warrant (SABSW) Key Ratios
$0.02
As on 08-Sep-2026 16:27EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -19.26 | -123.18 | 65.89 | 11.99 | -8.07 |
| Net Profit | -19.20 | -122.37 | 65.52 | 16.03 | -7.98 |
| EPS | 19.95 | 74.08 | 89.87 | 24.57 | -- |
| Book Value | -- | -- | 13.49 | -19.78 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -2,212.67 | -1,132.51 | -- | -- | -2,554.95 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -54.15 | -52.10 | -6.98 | 14.96 | -81.92 |
| Return on Capital
| -47.60 | -44.76 | -- | 14.11 | -72.68 |
| Return on Assets
| -34.53 | -31.37 | -8.79 | 12.23 | -53.23 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.04 | 0.18 |
The underlying data is unavailable.